Targeting the HGF/c-Met axis: state of play.
Yap
Timothy A
TA
de Bono
Johann S
JS
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems / Q000379:methods*; D005784:Gene Amplification; D017228:Hepatocyte Growth Factor / Q000037:antagonists & inhibitors* / Q000235:genetics; D006801:Humans; D009154:Mutation / Q000502:physiology; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors* / Q000235:genetics; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology
D000970:Antineoplastic Agents; D017228:Hepatocyte Growth Factor; D019859:Proto-Oncogene Proteins c-met